Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 207 of 1,261

  1. US 11591304

    SLC26A3 inhibitors and use thereof

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  2. US 11590135

    Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  3. US 11591402

    Neutralizing antibodies to the alpha v beta 8 integrin complex for immunotherapy

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  4. US 11590111

    Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

    Fulcrum Therapeutics, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  5. US 11594345

    Method for producing Ac-225 from Ra-226

    Ion Beam Applications · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  6. US 11591579

    Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

    The Board of Regents of the University of Texas System · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  7. US 11591369

    Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  8. US 11591622

    Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder

    Sangamo Therapeutics, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  9. US 11591332

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  10. US 11591330

    HIF-2a small-molecule inhibitor and use thereof

    China Medical University · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  11. US 11590234

    Hyperbranched polymers and polyplexes and DNA or RNA delivery systems including the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  12. US 11591316

    Compounds, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  13. US 11590222

    Antibodies that bind human C6 and uses thereof

    REGENESANCE B.V. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  14. US 11590204

    Use of C-type natriuretic peptide variants to treat skeletal dysplasia

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  15. US 11590205

    Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents

    XERIS PHARMACEUTICALS, INC. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  16. US 11590179

    Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection

    PrecisionBiotics Group Limited · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  17. US 11591372

    Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  18. US 11590156

    RNAi agents for hepatitis B virus infection

    Arrowhead Pharmaceuticals, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  19. US 11590171

    Targeted replacement of endogenous T cell receptors

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  20. US 11590223

    Dosing strategy that mitigates cytokine release syndrome for therapeutic antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  21. US 11590170

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  22. US 11590089

    Beta-2 selective adrenergic receptor agonists

    The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  23. US 11590113

    Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator

    Corcept Therapeutics Incorporated · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  24. US 11590154

    Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

    RedHill Biopharma Ltd. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.